ArticleScientific reports2026
Dietary restriction and aerobic exercise alleviate obesity-related skeletal muscle impairment via the miR-130/PPARγ axis and IGF-1/Akt/mTOR signaling activation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study investigated the effects of dietary restriction (DR) combined with aerobic exercise training (ET) on high-fat diet (HFD)-induced obesity and associated skeletal muscle impairment in male Sprague-Dawley rats, as well as the underlying mechanisms. An 8-week DR + ET intervention effectively increased the cross-sectional area and protein content of the soleus muscle. Both DR and ET alone promoted the activation of the IGF-1/Akt/mTOR signaling pathway and reduced the protein expression of peroxisome proliferator-activated receptor γ (PPARγ), a target of miR-130 in adipocytes, in HFD-induced obese rats. However, no additional benefit was observed with combined DR + ET treatment. Consistent with these findings, miR-130 expression was upregulated in the skeletal muscle of obese rats compared with those fed a normal diet, and this increase was significantly attenuated by DR, ET, or DR + ET, with DR + ET showing the strongest inhibitory effect. To further explore the role of miR-130 in skeletal muscle cells, L6 and C2C12 cells were transfected with miR-130 mimics. Overexpression of miR-130 markedly suppressed proliferation and differentiation in these cells, accompanied by reduced creatine kinase activity and decreased myogenin expression-both key markers of myogenic differentiation. Moreover, miR-130 overexpression inhibited the luciferase activity of a reporter vector containing the PPARγ-3'-UTR, and this inhibition was abolished by mutation of the PPARγ-3'-UTR, indicating a direct regulatory mechanism affecting protein synthesis in skeletal muscle. In summary, DR and ET each alleviated obesity-related skeletal muscle impairment by activating IGF-1/Akt/mTOR signaling and suppressing miR-130 expression, but their combination did not produce synergistic effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.